Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Andrzej Nycz
- Kuntal De
- Mingyan Li
- Sam Hollifield
- Udaya C Kalluri
- Alex Walters
- Biruk A Feyissa
- Brian Weber
- Bruce Moyer
- Chris Masuo
- Clay Leach
- Debjani Pal
- Isaac Sikkema
- Jeffrey Einkauf
- Jennifer M Pyles
- Joseph Olatt
- Justin Griswold
- Kevin Spakes
- Kunal Mondal
- Laetitia H Delmau
- Lilian V Swann
- Luke Koch
- Luke Sadergaski
- Mahim Mathur
- Mary A Adkisson
- Mike Zach
- Oscar Martinez
- Padhraic L Mulligan
- Sandra Davern
- T Oesch
- Vincent Paquit
- Xiaohan Yang

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

We present the design, assembly and demonstration of functionality for a new custom integrated robotics-based automated soil sampling technology as part of a larger vision for future edge computing- and AI- enabled bioenergy field monitoring and management technologies called

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Real-time tracking and monitoring of radioactive/nuclear materials during transportation is a critical need to ensure safety and security. Current technologies rely on simple tagging, using sensors attached to transport containers, but they have limitations.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

Due to a genes unique nucleotide sequences acquired through horizontal gene transfer, the gene has a transcriptional repressor activity and innate enzymatic role.

The invention provides a gene and methods for maintaining meiotic chromosomal architecture